Skip to main content
Uncategorized

SOM Biotech wins the EmprendedorXXI Award in life sciences

By 10 de October de 2013November 18th, 2020No Comments
< Back to news
Raúl Insa, SOM Biotech CEO. Source: "la Caixa".
 10.10.2013

SOM Biotech wins the EmprendedorXXI Award in life sciences

SOM Biotech, based in the Parc Científic de Barcelona, is one of the winners of the EmprendedorXXI 2013 Awards, the initiative for innovation projects organized by "la Caixa" in collaboration with the Ministry of Industry, Energy and Tourism, through ENISA (Empresa Nacional de Innovación). The EmprendedorXXI Awards, which this year reaches its 7th edition, are recognized as one of the best established initiatives to support entrepreneurship in Spain.


SOM Biotech has been awarded one of the three prizes in the ‘”creces’ category, specifically the award granted to life sciences – aimed at already established business projects, with relevant results, a market trajectory between 2 and 7 years, an ambitious growth plan and a team with high management capacity. Other companies such as the Valencia-based company From the Bench, in the field of digital technologies; and Murcia-based Symborg in industrial technologies, were also awarded in this category. Each of the winning companies will receive a prize of 50,000 Euros.

SOM Biotech, founded in December 2009, focuses its work on the research, identification, experimental validation, intellectual property protection, clinical proof of concept and licensing of new applications and medical indications of marketed drugs (repositioning or reprofiling). The identification is carried out using a virtual screening technological solution, developed by the own company.

The biotech collaborates with leading pharmaceutical companies worldwide , and has a broad portfolio of products under development covering both rare diseases (TTR amyloidosis , Huntington’s disease and glioblastoma multiforme ) and other therapeutic areas (Alzheimer’s disease and benign prostatic hypertrophy ). To present, it has analyzed more than 60 drugs and has filed five patents for new medical indications.

The EmprendedorXXI Awards have reached its 7th edition this year and have become one of the reference calls for entrepreneurs in Spain . They were created with the aim to identify, recognize and accompany recently created innovative start-up companies with a high growth potential. In this 2013 edition, the call has received a total of 665 applications from entrepreneurs from all over Spain (451 in the category ’emprendes ‘ and 214 in the category ‘creces’). The Awards´panel of judges praised the high level of innovation of the applicants´ business projects and great potential for growth of their companies.